Frank W G Leebeek

55PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oenology and viticultureApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

|Jan 17, 2025
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs.

Noa A Linthorst, Yvonne K Jongejan, Richard J Dirven

|Oct 21, 2024
Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpura.

A J Gerard Jansen, Minke A E Rab, Peter A W Te Boekhorst

|Oct 15, 2024
Patient-reported data on the severity of Von Willebrand disease.

Calvin B van Kwawegen, Karin Fijnvandraat, Marieke J H A Kruip

|Jun 19, 2024
Early Postoperative Changes in Von Willebrand Factor Activity Are Associated With Future Bleeding and Stroke in HeartMate 3 Patients.

Parsa Jahangiri, Kevin M Veen, Iris van Moort

|Mar 11, 2024
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy.

Robbin Itzler, Tyler W Buckner, Frank W G Leebeek

Pageof 10

Frequent Collaborators

12 joint publications

Jeroen Eikenboom

12 joint publications

Marieke J H A Kruip

11 joint publications

Ferdows Atiq

10 joint publications

Samantha C Gouw